$17.18
-0.22-1.26%
At close: -
$17.18
0.000.00%
After Hours: Dec 20, 4:05 PM EDT
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
There have been no specific sales or earnings guidance reported for Travere Therapeutics in recent months.
Browse guidance and forecast on all stocks.